Artemis Therapeutics, Inc. (ATMS)
Stock Price: $0.2540 USD
-0.2560 (-50.20%)
Updated Mar 5, 2021 9:53 AM EST - Market closed
| Market Cap | 1.31M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -63,000 |
| Shares Out | 5.15M |
| EPS (ttm) | -0.01 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Dividend Yield | n/a |
| Trading Day | March 5 |
| Last Price | $0.2540 |
| Previous Close | $0.5100 |
| Change ($) | -0.2560 |
| Change (%) | -50.20% |
| Day's Open | 0.2540 |
| Day's Range | 0.2540 - 0.2540 |
| Day's Volume | 100 |
| 52-Week Range | 0.034 - 0.809 |
News
There are no news available yet.
About ATMS
Artemis Therapeutics does not have significant operations. Previously, it was engaged in the development of agents for the prevention and treatment of severe and life-threatening infectious diseases. The company was incorporated in 1997 and is based in New York, New York.
| Industry Biotechnology | |
| Stock Exchange OTCMKTS | Ticker Symbol ATMS |